Document
Academic Article
Generically Dependent Continuant
Article
Information Content Entity
Phase II study of afatinib, an irreversible ErbB family blocker, in EGFR FISH-positive non-small-cell lung cancer
RDF description of Phase II study of afatinib, an irreversible ErbB family blocker, in EGFR FISH-positive non-small-cell lung cancer - http://irises.uninsubria.it/resource/item/143816